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INTRODUCTION 
 Regional anaesthesia as the name implies is the blocking of 
peripheral nerve conduction in a reversible manner by using local 
anaesthetic agents thereby one region of the body is made insensitive to 
pain and is devoid of reflex response to surgical stimuli. The central 
nervous system is spared, so the patient is conscious during the surgical 
procedure. 
 Regional anaesthesia offers many advantages over general 
anaesthesia for surgery on upper extremities particularly in emergency 
operations. 
Advantages of Regional over General Anaesthesia 
 
¾ Completely attenuates rather blocks stress response and 
attended stress hormones release. 
¾ Causes least disturbance to the normal physiology than any 
other type of anaesthesia. 
¾ Proven to be safe for high risk patients who are in greater risk 
due to stress imposed by general anaesthesia. 
¾ Only method of anaesthesia, which prevents all afferent 
impulses from the site of surgery reaching the central nervous 
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system. Hence the need for polypharmacy and its attented risks 
are eliminated.  
¾ Along with complete pain relief and total muscle relaxation, it 
produces vasodilatation, which improves blood circulation and 
prevents tissue hypoxia. 
¾ Many intraoperative and post operative complications of 
general anaesthesia are avoided. 
¾ Postoperative pain relief is ensured for a longer duration by 
using long acting local anaesthetics and for several days if 
continuous block using catheter technique is employed. 
¾ It is cost effective & safe 
¾ Avoids theatre pollution. 
¾ Safest technique for patients with full stomach. 
¾ All adverse effects of airway manipulation can be avoided. 
Brachial plexus can be blocked by different approaches 1-4, but the 
ones frequently employed for blocking brachial plexus include. 
(a) Inter scalene approach 
(b) Supraclavicular approach 
(c) Infraclavicular approach 
(d) Axillary approach 
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Interscalene approach 
 
 
 
 
Supraclavicular approach 
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Infraclavicular approach 
 
 
 
Axillary approach 
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Axillary1 approach has the lowest incidence of serious 
complications and can be performed with ease. But there are limitations 
associated with axillary approach like 
¾ Unlike in paediatric age group each and every nerve is enclosed 
in separate sheaths in adults. 
¾ It is inadequate for operations on the arm & shoulder  
¾ It is difficult to block the musculocuteneous nerve predictably 
with resultant sparing of the radial aspect of forearm and 
dorsum of the hand. 
¾ Tourniquet pain is not well tolerated. 
¾ Also abducting the arm by 90° for giving the block may be 
painful and even dangerous in traumatic lesions of the upper 
extremity. 
 
 
 
 
 
The brachial plexus is approached at the level of the trunks and the 
compact arrangement of trunks at supraclavicular level gives a high 
success rate with minimum local anaesthetic drug volume and a dense 
and fast onset block. Hence the supraclavicular approach is the method of 
choice for blocking the brachial plexus. 
CT of axillary block 
showing contrast medium 
to remain in three separate 
compartments 
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William Steward Halsted first performed brachial plexus block is 
1885. In 1911 Kulemkampff and Hirschel described the first 
percutaneous brachial plexus block by supraclavicular and axillary routes 
respectively. 
Since then several techniques of brachial plexus block have been 
described with the purpose of improving the efficacy and success rate and 
minimizing the risk and rate of complications. Of the various techiques 
the most widely used methods are classical technique described by 
Patrick (1940), Vertical plump bob approach described by Brown, 1st rib 
walk over technique described by Bonica & Moore and subclavian 
perivascular technique described by Winnie and Collins (1964). 
Of the several local anaesthetic drugs used for brachial plexus 
block, Bupivacaine is used most frequently as it has a long duration of 
action varying from 3 – 8 hours. 
To prolong the duration of analgesia various drugs have been 
studied as adjuvants to local anaesthetic solution and techniques like the 
continuous catheter placement in the plexus have evolved. These adjuvant 
drugs ideally are expected to prolong the analgesic effect without causing 
any systemic side effects or prolonging motor blockade. Commonly used 
additives to local anaesthetic solutions are epinephrine, clonidine and 
opioids 40,41, benzodiazepines and phenylephrine. 
 7
Clonidine 8-12 an α2 adrenergic agonist has been extensively 
studied as an adjunct to general and regional anaesthesia. It has been 
shown to produce this effect by activation of postsynaptic adrenergic 
receptors 13. 
Fentanyl an μ-receptor agoinst has also been used widely in 
intrathecal, extradural and peripheral nerve plexus blockade33-38. 
Midazolam, a water soluble benzodiazepine, is known to produce 
antinociception 48,49 and to enhance the effect of local anaesthesia when 
given epidurally or intrathecally 50-54. Midazolam produces this effect by 
its action on GABA – A receptors 48,51,54. The presence of GABA 
receptors in peripheral nerves is also demonstrated 44,46,55. 
This study is intented to determine and compare the effects of 
adding additives like clonidine, fentanyl and midazolam to bupivacaine in 
brachial plexus blockade by supraclavicular approach with regard to 
onset, and blockade duration of blockade along with its analgesic efficacy 
and quality of analgesia and sedation. 
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AIM OF THE STUDY 
 The aim of the present study is to evaluate the effects of addition of 
1 mcg / kg of preservative free clonidine to the maximum of 75 mcg,  
1 mcg / kg of preservative free fentanyl to the maximum  of 50mcg and 
50mcg / kg of preservative free midazolam to 30ml of 0.25%. 
Bupivacaine solution in supraclavicular brachial plexus block with regard 
to 
¾ Onset of blockade 
¾ Duration of blockade 
¾ Quality of analgesia 
¾ Sedation 
¾ Hemodynamic stability 
¾ Complications if any 
 9
 
ANATOMY OF THE BRACHIAL PLEXUS1-4 
 
 Knowledge of the formation of brachial plexus and of its 
distribution is absolutely essential for the precise and effective use of 
brachial plexus analgesia for surgeries of the upper limb. A thorough 
understanding of the vascular, muscular and fascial relationships of the 
plexus thoroughout its formation and distribution is equally essential in 
order to master the various techniques of brachial plexus analgesia. 
 In its course from the inter vertebral foramina to the arm, the fibres 
that constitute the plexus are composed consecutively of roots, trunks, 
divisions, cords and terminal branches which are formed through 
complex process of combining, dividing, recombining and finally 
redividing. 
 The brachial plexus is formed by the union of anterior primary 
rami of the fifth to eighth cervical nerve and first thoracic nerve with 
occasional contributions from the fourth cervical nerve (prefixed) above 
and second thoracic nerve (post fixed) below. These nerves unite to form 
trunks, which lie in the neck above the clavicle. Its roots pass through the 
fascia enclosed space between the scalenus anterior and the scalenus 
medius accompanied by the subclavian artery and invaginate the scalene 
fascia to form a neurovascular bundle. This fascia becomes axillary 
sheath in the axilla. 
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Relations of Brachial plexus 
Anterior relations 
 The skin, superficial fascia, platysma, and supraclavicular branches 
of the superficial cervical plexus, the deep fascia and external jugular 
vein. The clavicle is in front of the lower part and scalenus anterior is in 
front of the upper part. 
Posterior Relations 
 Scalenus medius and the long thoracic nerve of bell. 
Inferior relations 
 Related to the first rib 
Superior relations 
 Lies first above and then lateral to the subclavian artery. 
Sympathetic contribution to the plexus 
 Close to their emergence, the 5th & 6th cervical nerves, each receive 
a grey ramus from the middle cervical sympathetic ganglion. The 7th and 
8th cervical nerves receive a grey ramus from the inferior cervical 
ganglion. 
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Roots 
 Anterior primary rami of C5-C8 and T1(Occasionally C4 & T2) 
Trunks 
¾ Upper trunk – anterior  rami of C5 and C6 
¾ Middle trunk – anterior rami of C7 
¾ Lower trunk – anterior ramus of C8 and T1 
Divisions 
 Behind the clavicle, each trunk divides into anterior and posterior 
divisions. 
Cords 
¾ Lateral cord - Anterior divisions of upper and  middle trunks 
    (C5-C7) 
¾ Medial cord - Anterior division of lower trunk  (C8-T1) 
¾ Posterior cord - Posterior divisions of all the three trunks  
    (C5-T1) 
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Branches 
 From Roots 
 
¾ Nerve to serratus anterior (C5-C7) 
¾ Muscular branches to longus cervices C5-C8 
¾ Nerve to three scalene C5-C8 
¾ Nerve to Rhomboids C5 
¾ A twig to phrenic nerve C5. 
From Trunks 
¾ Supra scapular nerve C5 & C6 
¾ Nerve to subclavius C5 & C6 
From Cords 
• Lateral cord  
o Lateral pectoral nerve C5-C7 
o Lateral Root of Median nerve C5-C7 
o Musculo cuteneous nerve C5-C7 
• Medial cord  
o Medial pectoral nerve C8-T1 
o Medial root of median Nerve C8-T1 
o Medial Cuteneous Nerve of Arm C8-T1 
o Medial Cuteneous Nerve of forearm C8-T1 
o Ulnar nerve C8-T1 
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• Posterior cord  
o Radial nerve C5-T1 
o Axillary nerve C5-C8 
o Thoracodorsal nerve C6-C8 
o Upper and lower subscapular (C5-C6) 
 
Sensory innervation of arm  
 
Familiarity with the perineural structures that surround and 
accompany the brachial plexus as it leaves the vertebral column on its 
course to the upper arm is important as the knowledge of the formation 
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and distribution of the neural plexus it self. Palpable muscular and 
vascular landmarks allow accurate location of the plexus per cuteneously. 
An appreciation of the fascial relations is absolutely essential since this is 
the basis for all the perivascular techniques. 
After leaving the intervertebral foramina, the anterior primary rami 
of the nerves destined to become the brachial plexus travel in the gutter 
formed by the anterior and posterior tubercles of the corresponding 
transverse process of the cervical vertebra. After leaving the transverse 
process, the roots of the plexus descend in front of the middle scalene 
muscle, which arises from the posterior tubercles of the transverse 
process of the lower six cervical vertebra. The insertion of this muscle on 
the first rib is separated from that of the anterior scalene muscle by the 
inferior trunk of the brachial plexus. The anterior scalene muscle arises 
from the anterior tubercles of the transverse process of 3rd – 6th cervical 
vertebra & inserts on the scalene tubercle of the first rib, thus separately 
subclavian artery from the subclavian vein. 
The fascia covering both the scalene muscles is derived from 
prevertebral fascia which splits to invest these muscles and then fuses 
again at their lateral margins to form an enclosed interscalene space. 
Therefore, as the roots leave the transverse process they emerge between 
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two walls of the facia covering the anterior and middle scalene muscle. In 
their descent toward the first rib to form the trunks of the plexus, the roots 
may be considered to be sandwiched between anterior and middle scalene 
muscles, the fascia of which serves as a sheath of the plexus. As the 
trunks approach the first rib, they are rearranged as superior, middle and 
inferior trunks.  
As the trunks of the plexus cross the first rib, they are joined by the 
subclavian artery, which lies in a plane anterior to the trunks, so that the 
inferior trunk lies behind the artery in the subclavian groove with the 
middle and superior trunks above the level of the vessel. At this level the 
artery and trunks are moving laterally across the ribs and invaginate the 
scalene fascia to form the subclavian perivascular space, which is 
continuous medially and superiorly with the inter scalene space and 
inferiorly and laterally with axillary perivascular space. 
The important concept is that there is a continuous fascia enclosing 
the perineural and perivascular  space extending from cervical transverse 
process to several centimeters beyond the axilla. This space has been 
divided in to an axillary perivascular space and an inter scalene space. 
The existence of such a continuous perineural space renders brachial 
plexus block simple. The space described may be entered at any level, 
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and the volume of the anaesthetic injected at that level would determine 
the extent of anaesthesia. Thus, the technique to be used in any case 
should be determined on the basis of the surgical site, the required level 
of anaesthesia, the physical status and habitus of the patient. 
The upper medial aspect of the arm is not anaesthetised by any 
brachial plexus block technique, since this area is innervated by the 
intercosto brachial nerve T2. This nerve can be blocked by  subcutaneous 
infiltration across the upper medial aspect of the arm using 3-5 ml of 
local anaesthesia solution for surgical anasthesia or tourniquet. 
The brachial plexus can be blocked at the level of the roots, trunks, 
cords or peripheral branches. The block at each level has a distinct 
distribution of anaesthesia, advantages, disadvantages and complications. 
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CLINICAL PHARMACOLOGY 
Bupivacaine 
 Sythesised by Evenstam in 1957 in Sweden  
First came in to clinical use in 1963. 
 Bupivacaine is an anilide compound 
 It is an amide Local Anaesthetic (1-butyl-N-(2,6,dimethyll phenyl-
piperidine – 2 – Carboxamide). 
 
Presentation  
 As a clear 0.25%, 0.5%, 0.75% solution of bupivacaine 
hydrochloride. The hyperbaric solution used for subarachnoid block 
contains 80mg/ml  of glucose. 
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Physiochemical Properties 
 Pka   : 8.1 
 Protein binding : 96% 
 Lipid solubility : 28 
 Elmination T½   : 210 mins 
 Clearance   : 0.4 7 l / min 
MECHANISM OF ACTION 
 Local anaesthetics such as bupivacaine block the generation and 
the conduction of nerve impulses, presumably by increasing the threshold 
for electrical exitation in the nerve, by slowing the propagation of the 
nerve impulse, and by reducing the rate of rise of the action potential. In 
general, the progression of anaesthesia is related to the diameter, 
myelination and conduction velocity of affected nerve fibres. Clinically, 
the order of loss of nerve function is as follows. 
(1) Pain  
(2)  temperature  
(3)  touch 
(4) Proprioception and 
(5) Skeletal muscle tone. 
 19
The analgesic effects of bupivacaine are thought to be due to its 
binding to the prostaglandin E2 receptors, subtype EP1, (PGE2 EP1] 
which inhibits the production of prostaglandins thereby reducing fever, 
inflammation and hyperalgesia. 
Routes of administration / doses 
 Bupivacaine may be administered topically by infiltration, 
intrathecally, epidurally. The therapeutic dose of Bupivacaine is  
2-3mg/kg (with or without adrenaline) 
 The drug acts within 10-20 mins and has a duration of action of 5-6 
hours. 
Pharmacokinetics 
 The absorption of Local Anaesthetic is related to 
• The site of injection (intercostal > epidural > brachial plexus 
> Subcuteneous) 
• The dose – a linear relationship exits between the total dose 
and the peak blood concentration achieved. 
• The presence of vasoconstrictors which delay absorption. 
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The addition of adrenaline to bupivacaine does not influence the 
rate of systemic absorption as,  
 The drug is highly lipid soluble and therefore uptake into fat is 
rapid. 
 The drug has a direct vasoconstrictor effect. 
The possible pathway for metabolism of bupivacaine include 
aromatic hydroxylation, N-dealkylation, amide hydrolysis and 
conjugation. Only the N-dealkylated metabolite N-desbutyl bupivacaine 
has been measured in the blood or urine. 
Alpha-1 acid  glycoprotein is the most important protein binding 
site of bupivacaine. 5% of the dose is excreted in the urine as 
pipcolloxylidine. 16% is excreted unchanged clearance is 0.47 L/min and 
elimination T½ is about 210 min. 
Systemic Toxicity 
Cardiovascular system 
Bupivacaine is markedly cardiotoxic. It binds specifically to the 
myocardial proteins. In toxic concentrations the drug decreases the 
peripheral vascular resistance and myocardial contractility producing 
hypotension and possible cardiovascular collapse. Cardiotoxic plasma 
concentrations of bupivacaine is 8-10 mcg/mL. 
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CENTRAL NERVOUS SYSTEM 
 The principal effect of bupivacaine is reversible neural blockade. 
This  leads to a characteristically biphasic effect in the CNS. During 
accidental over dosage or direct vascular injections the clinical signs are 
numbness of tongue, lightheadedness, visual  and auditory  disturbances, 
muscular twitchings, tremors. The signs may progress to generalised 
convulsions of the tonic clonic nature. When plasma levels continue to 
rise, CNS excitation is rapidly superceded by depression drowsiness, 
disorientation & coma. The typical plasma concentration of Bupivacaine 
associated with seizures is 4.5 – 5.5 mcg/mL. 
Pharmacology of Clonidine 
 Clonidine is a prototype, partially selective alpha-2 adrenoreceptor 
agonist (alpha 2; alpha-1) 220:1. It is a centrally acting imidazole 
compound. It was synthetised in the early 1960's as a vasoconstricting  
nasal decongestant. 
STRUCTURAL  FORMULA 
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MOLECULAR FORMULA 
 (2-(2,6 – dicholorophenyl amino) – 2- imidazoline)  
Physical Property 
 Molecular Weight : 226.56  
Preparations 
 i. Tablets – 0.1mg, 0.15mg, 0.2mg, 0.3mg 
 ii. Injection (parenteral) 0.15mg /ml ampoule (1ml) 
iii. Injection (preservative free) For epidural & spinal injection 
(0.1mg/ml) 
iv. Transdermal Therapeutic Patch release 
Routes of Administration 
 It can be given as oral tablets, intraveneous injection,  subarachnoid 
or epidural injection, as an additive for regional nerve blocks. 
Pharmacokinetics 
 Oral clonidine is well absorbed with a bio-availability of nearly 
100%. The onset of action starts from 30-60 minutes. The peak effect is 
between 60 to 120 minutes and its action lasts for upto 8 hours. Clonidine 
has a low to moderate protein binding capacity (20-40%) It has an 
elimination half-life of 6-24 hours with a mean duration of about 12 
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hours. The elimination half life is increased upto 40 hours in patients with 
renal dysfunction. 
 There is good correlation between plasma concentration of 
clonidine and its pharmacological effects. 
Plasma Concentration of  
clonidine  mg/ml 
Pharmacological effects 
About 1 Salivary flow reduced 
> 1.5 – 2 Sedation to sleep 
upto 1.5-2 Hypotension 
> 2 Vasoconstriction to Hypertension 
 
METABOLISM & ELIMINATION 
 Nearly 50% of clonidine is eliminated in the urine and remaining 
drug  undergoes hepatic biotransformation. Biliary and faecal excretion is 
responsible for 20% of drug elimination. 
Pharmaco dynamics 
 Clonidine acts on various systems in the body. 
Cardio Vascular System 
 Clonidine has got both central action and peripheral action. 
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Central Action 
 Activation of central α - 2 adrenergic receptors in medullary 
vasomotor centre inhibits the release of nor – epinephrine from the 
adrenergic neurons and reduces sympathetic outflow from the central 
nervous system. Further there is reduced discharge from the post 
ganglionic fibers of cardiac nerves and an increase in parasympathetic 
tone. 
 This results in decrease in blood pressure, heart rate, cardiac 
output, peripheral vascular resistance. Nucleus tractus solitarius, the site 
that modulates the autonomic control including vagal activity is an 
important central site for the action of clonidine. 
 Other proposed sites of action are locus ceruleus, dorsal motor 
nucleus of vagus and nucleus reticularis lateralis. 
 Reduction in sympathetic tone is accompanied by lowering of 
plasma renin activity, decrease in renal vascular resistance and 
maintenance of renal blood flow even when the blood pressure is 
lowered. Vasopressor centers of the brainstem retain their sensitivity to  
baroreceptor control and hence postural  hypotension is considerably less 
than the effects of drugs that act on the autonomic ganglia and peripheral 
adrenergic receptors. 
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 The absence of fall in blood pressure when clonidine is given to 
tetraplegic with complete spinal cord transection above the level of 
sympathetic outflow also suggests a central site of hypotensive action. 
Peripheral Action  
These are mediated by inhibition of nor – epinephrine release from 
the peripheral prejunctional nerve endings and by decreasing plasma 
concentration of nor-epirephrine. 
Coronary Circulation 
 The direct effect of α-2 agonist on coronary vasulature is 
vasoconstriction. However, this is offset by the generalised reduction in 
sympathetic outflow. 
Central Nervous System 
 Clonidine has got a sedative and anxiolytic action. The sedative 
effect of clonidine may be due to decreased tonic activity of the locus 
coeruleus which modulates the stimuli arriving in the central nervous 
system. It has got a potent spinal and supraspinal analgesic action. 
Clonidine has got opioid sparing effect and it reduces the anaesthetic 
requirements, reduces the MAC of halothane and isoflurane. 
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Respiratory System 
  Clonidine has minimal bronchodilating and respiratory depressant 
activity. 
Endocrine System 
 Clonidine suppresses insulin secretion, decreases utilisation of 
glucose by tissues and may cause hyperglycemia. It inhibits the secretion 
of renin. 
Gastrointestinal System 
 Clonidine decreases salivary flow. It prevents intestinal ion & 
water secretion in the large bowel. 
Uses:    
1. Preanaesthetic medication 
 Clonidine in dose 3-5 mcg/kg orally 60-120 mins prior to 
induction given as a premedicant provides sedation, anxiolysis, 
antisialagogue effect, attenuates the hemodyanamic responses to 
largyngoscopy and intubation, decreases the intra operative lability of 
blood pressure, heart rate and decreases post anaesthetic shivering. 
2. Spinal & Epidural Analgesia 
 Preservative free clonidine injected epidurally (2-10mcg/kg) or in 
to subarachnoid space (0.3 – 3mcg/ kg) produces dose dependant 
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analgesia. It acts on the substantia gelatinosa of the spinal cord, inhibits 
substance `p' release and nociceptive neuron firing produced by noxious 
stimuli. 
3. Prolonging the effects of Reginal Anaesthesia 
 When added to local anaesthetic solution prolongs the brachial 
plexus block and caudal analgesia. 
4. Treatment of Post anaesthetic shivering. 
 Injection clonidine 3 mcg/kg given intravenously inhibits or stops 
shivering mechanism by inhibition of central thermoregulatory control. 
5. Diagnosis of Pheochromocytoma 
 Lack of suppression of plasma nor-epinephrine to less than 500 
picogram / ml, 3 hours after a oral dose of 0.3 mg clonidine suggests 
pheochromocytoma. 
6. Treatment of Hypertension 
 It is not used as a first line antihypertensive 
7. Induced hypotension 
 Clonidine is a useful adjunct in inducing deliberate hypotension. 
Adverse Effects 
 Clonidine can cause bradycardia, hypotension, sedation and dry 
mouth occur in 50% of cases. It may cause dryness of nose and eyes. It 
may sometimes cause parotid swelling and pain. Less common side 
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effects like sleep disturbances with vivid dreams or nightmares 
restlessness, depression and impotence may occur in some patients. 
Clonidine withdrawal phenomena 
 Abrupt discontinuation of clonidine results in headache, 
apprehension, tremors abdominal pain, sweating, tachycardia 
hypertension. It occurs usually 18-24 hours after stopping the drug. It 
occurs because of increased sympathetic discharge resulting in increased 
plasma and urine catecholamine concentration. It is dose related, occuring 
rarely in patients taking a daily dose of clonidine 0.3mg or less and more 
frequently upon discontinuation of higher doses of > 1.2mg/day. 
Drug Interactions 
 
 1) Diuretics potentiate hypertension caused by clonidine  
 2) Tricyclic antidepressants inhibit the antihypertensive effect 
  of clonidine by a unknown mechanism. 
Overdose 
 It results in depression of sensorium, transient hypertension 
followed by hypotension and bradycardia. It may cause respiratory 
depression and miosis resembling opioid overdose. Treatment is 
ventilatory support and circulatory support with crystalloids, colloids 
ionotropic support. 
 29
PHARMACOLOGY OF FENTANYL 
Structure 
 4 anilinopiperidines that are structurally similar to pethidine. 
 
 Fentanyl is a synthetic opioid with morphine like actions. Act at μ  
receptor as a agonist. It is  more specific, shorter acting &  80 – 100 times 
more potent than morphine. 
PHARMACOKINETICS & PHYSIOCHEMICAL PROPERTIES 
 Property     Value 
 Pka      8.4 
 % of unionised at PH 7.4   <10 
 % bound to plasma protein   84 
 t½ μ      1-2 mins 
 Volume of distribution   0.5 – 1.0L/kg 
 Clearance     10-20mL/kg/min 
 Hepatic extraction ratio   0.8 – 1.0 
 30
Pharmaco Dynamics of Fentanyl 
Cardio Vascular System 
 Bradycardia – Vagal stimulation in high doses. 
 No effect on cardiac contractility  
Hypotension in large doses due to bradycardia, venodilation and 
suppression of central sympathetic out flow. 
Respiratory System 
 Dose dependant respiratory depression through direct effect on 
medullary respiratory  centre. Effects are: 
 Apnoeic  threshold increased. 
 Hypoxic drive decreased. 
 Delayed respiratory depression. 
CNS 
 Analgesia, Euphoria, Sedation, Hypnosis, Miosis, 
 GIT – delays gastric emptying, produces biliary colic, nausea, 
vomiting. 
Endocrine System : Attenuates the stress response 
 Side Effects : Pruritis, nausea, vomiting, urinary retention, apnoea, 
seizures, chest wall regidity. 
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Pharmacology of  Midazolam 
 Midazolam is a water soluble imidazobenzodiazepine (8-chloro-6- 
(2-flurophenyl)-1-methyl – 4H – imidazo (1, 5 - 9) (1, 4) Benzodiazpine) 
and its unique feature being its PH dependant imidazole ring which opens 
at pH < 4 and accounts for its stability in aqueous solution and rapid 
metabolism. At pH > 4, the ring closes leading to increase in lipid 
solubility. 
 
C18 H13 ClFN3 
Pharmaco Kinetics 
• It has a PH of 3.5 with Pka of 6.15 
• Protein binding : 96% - 98% 
• Volume of distribution : 1-1.5l/kg 
• Clearance: 6-8ml/Kg/min 
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• Elimination halftime : 1.4 hrs. Increased in elderly & obese 
• Metabolised by hepatic microsomal enzyme cytochrome P-450 
by hydroxylation to 1OH and 4OH midazolam. 
Excreted in urine as glucuronide conjugates Erythromycin 
decreases its hepatic clearance leading to increased duration of action. 
Less than 0.02%  is excreted unchanged. Therefore it is not affected by 
renal failure. 
Mechanism of action 
 It is thought that the actions of benzodiazepines such as midazolam 
are mediated through the inhibitory neurotransmitter gamma-aminobutyic 
acid (GABA), which is one of the major inhibitory neurotransmitters in 
the brain. Benzodiazepines increase the activity of GABA, thereby 
producing a calming effect, relaxing skeletal muscles, and inducing sleep. 
benzodiazepines act as agonist at the benzodiazepine receptors, which 
form a component of the benzodiazepine GABA receptor – chloride 
ionophore complex. Most anxiolytics appear to act through atleast one 
component of this complex to enhance the inhibitory action of GABA.   
Dosages & Routes of Administration 
 Routes: Oral, Nasal, IM, IV, intrathecal & epidural  
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Dosage 
 Sedation  : 0.05 – 0.1 mg/kg 
 Pre-medication : 0.07 – 0.08 mg/kg 
 Induction  : 0.1 – 0.3 mg/kg 
 Infusion  : 2 – 5 mcg/kg/min 
 Intrathecal  : 0.3 – 2mg 
 Epidural  : 0.1 – 0.2 mg/kg. 
Actions 
Central Nervous System 
 Decreases cerebral blood flow,  cerebral O2 requirement and intra 
cranial pressure. 
 Sedation, Hypnosis, Anxiolysis, Antegrade amnesia, Anti 
convulsant. 
Respiratory System 
 Transient apnoea occurs when administered in doses greater than 
0.15mg/kg and in opiod  premedicated patients. 
 Potent respiratory depressant especially in COPD patients. 
Cardiovascular System 
 Decrease in peripheral vascular resistance and transient alteration 
of baroreceptor reflexes leading to hypotension and tachycardia. In 
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hypovolemic and elderly patients there is increased risk of significant 
hypotension. 
Local effects 
 No venous irritation & thrombophlibitis. 
Mechanism of pain relief in Central Neuraxial Blockade 
 It acts on spinal GABA receptors. There are 2 types of GABA 
receptors. GABA-A and GABA-B. Midazolam binds to the alpha subunit 
of the pentamer GABA-A  receptors leading to its conformational change 
causing increased chloride ion conductance and hyperpolarisation and 
thereby acts potentiating the inhibitory neurotransmitter, GABA. This is 
mainly a post synaptic action while GABA-B receptors mainly have 
presynaptic antinociceptive effect by decreasing the excitatory 
neurotransmitter release. 
 Intrathecal midazolam positively modulates GABA-A/ 
Benzodiazepine receptor complex causing the release of an endogenous 
opioid acting at opioid receptors and also intrathecal midazolam  causes 
anti-nociception by combining with three different receptor subtypes of 
GABA-A in the spinal cord. 
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PHARMACOKINETICS OF LOCAL ANAESTHETIC IN 
BRACHIAL PLEXUS BLOCKADE 
 When a local anaesthetic is injected around a nerve trunk, it will 
soak the trunk is an advancing front. Transmission in fibres situated in the 
periphery of the trunk (mantle fibres) will be first blocked and those in 
the centre of the trunk (core fibres) last. Further transmission, in 
peripherally placed fibres will be blocked over a longer length of time 
compared to central fibres. Thus analgesia will appear first and last 
longest in the territory supplied by peripheral fibres. If the pool of local 
anaesthetic is small or of the injection was not accurate or too dilute, the 
fibres in the centre of the trunk escape blockade. 
Theory of Winnie 
 The trunks are arranged so that the central fibres are the longest, 
supplying the extremities of the limb while the shorter fibres are arranged   
more peripherally as their area of supply is more proximal. Winnie 
groups the fibres in to two: the peripheral mantle fibres which contain the 
motor fibres and core fibres which are mainly sensory. Peripheral motor 
fibres supply the muscles of the forearm and the central fibers carry 
sensation from the hand. 
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REVIEW OF LITERATURE 
Technique and Drug 
 The supraclavicular brachial plexus block is one of several 
techniques of the brachial plexus. The block is performed at the level of 
brachial plexus trunks confined to a very small surface area. It produces 
rapid onset, predictable and dense anaesthesia. Kulenkmapff of Germany 
in 1911 performed the first precuteneous supraclavicular approach. This 
technique was later published in 1928 by Kulenkampff and Persky 
(Classic approach). 
Clonidine  in brachial Plexus Block 
1. Daniel M. Popping, Nadir Elia et al.13, in Anaesthisiology 2009 
have said that use of clonidine 30-300mcg, mostly 150mcg added 
to Bupivacaine have observed that time to onset of sensory block 
was significantly reduced when using clonidine. Duration of 
sensory  and motor block was significantly prolonged in clonidine 
group. Duration of postoperative analgesia was significantly 
increased in clonidine group. 
2. Hutschala D, Mascher H, Sohmetterer L, Klimschaw, Fleck T,  
et al5 have studied the effects of clonidine added to bupivacaine 
enhances and prolongs analgesia after brachial plexus block via a 
local mechanism in healthy volunteers. They studied the effects of 
clonidine 2 mcg /kg Plus 0.25% of Bupivacaine 1mg/kg in 7 
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healthy volunteers with a control treatment of  local analgesic with 
0.9% NaCl solution for the block and intra muscular injection of 
saline. The results were, the mean duration of sensory blockade 
was 270 mins in clonidine block when compared to `O' minutes for 
control treatment. Administration of clonidine was associated with 
sedation and a decrease in heart rate and blood pressure 
independent of the route of administration.  
3. Carabine UA, Milligan KR, Moorej et al11 of Department of 
Anaesthetics, Queen's University, Belfast have assessed the use of 
clonidine and bupivacaine for postoperative analgesia. Both drugs 
were administered via extradural route. The analgesia produced by 
clonidine was superior to that of bupivacaine alone.  
4. Erlacher W, Schuschnig C, Koinig H, Marhofer P et al 6,7 of 
Department of Anaesthesia and IC Hospital Vienna, Austria have 
studied Clonidine as adjuvant for mepivacaine, ropivacaine and 
bupivacaine in axillary perivascular brachial plexus block. 120 
trauma patients were randomly allocated in to six groups. Brachial 
plexus block was performed using 40ml of drug plus 1ml 
(0.150mg) of clonidine, with the control of 40ml of local 
anaesthetic solution + 1ml of NaCl 0.9%. They found that 
Mepivacaine groups showed a rapid onset and the ropivacaine and 
bupivacaine groups had a longer onset time. They concluded that 
addition of clonidine has a different impact on each of the three 
 38
local anaesthetics investigated in terms of onset and duration of 
block.  
5. Duma A, Urbanek B, Sitzwohlc, Krieger A et al 9 have performed a 
randomised controlled study of clonidine as a adjuvant to local 
anaesthetic axillary brachial plexus block. 20 patients each were 
investigated using 40ml of levo bupivacaine 0.5% plus 0.150mg of 
clonidine and 40ml of levobupivacaine 0.5% plus 1ml of NaCl 
0.9% and 40m of bupivacaine 0.5% plus 0.150mg of clonidine and 
40ml of bupivacaine 0.5% plus 1ml of NaCl  0.9% respectively. 
There was a significant higher variance (P < 0.001) was found in 
the 2 group with clonidine than in two groups without clonidine. 
6. Bhatnagar S, Mishra S, Madhurima S, Gurjar M, Mondal10AS 
Dept. of  Anaesthesiolosy, Institute Rotary Cancer Hospital, 
AIIMS, New Delhi have performed randomized study of clonidine 
as adjuvant to continuous paravertebral bupivacaine for post – 
thorocotomy pain. They evaluated the effects of clonidine as an 
adjuvant to bupivacaine for continuous paravertebral intercostal 
nerve block, measuring pain and sedation scores and PFT. Thirty 
patients scheduled to undergo thorocotomy were randamized to 
receive either a bolus of 0.125%. Bupivacaine 2mg/kg or 
bupivacaine 2mg/kg with clonidine 2mcg/kg . They concluded that 
clonidine as an adjunct to bupivacaine for continuous paravertebral 
intercostal nerve block improves pain relief after thorocotomy, but 
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hypotension and sedation are adverse effects interfering with its 
clinical application. 
7. El Saied, Stenyn et al15 have observed that addition of clonidine 
150mcg prolongs the effect of Ropivacaine for axillary brachial 
plexus blockade. 
8. Jean J. Eledjan, Jacques Deschodt et al12 have observed that 
addition of clonidine to Bupivacaine brachial plexus is a attractive 
alternative to epinephrine to prolong the duration of analgesia 
following upper limb surgeries under conduction anaesthesia. 
FENTANYL IN BRACHIAL PLEXUS 
1. Kohki Nishikawa MD, Noriaki Kanya, MD, Ph.D, Masayasu 
Nakayama et al 36,39 of Department of Anaesthesiology, Japan have 
evaluated the effects of fentanyl added to lignocaine for axillary 
brachial plexus block in 66 patients for elective hand and forearm 
study. In this double blinding study all patients received 40ml of 
1.5% lignocaine with 1:200,000 epinephrine and randamized in to 
3 groups receiving 2ml of normal saline, 100mcg of fentanyl in the 
block and 100mcg of fentanyl IV. They concluded that addition of 
fentanyl to lidocaine causes an improved success rate of sensory 
blockade. IV fentanyl had no effect on success rate, onset or 
duration of blockade. 
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2. Karakaya D, Buyukgoz F, Baris S et al33 have evaluated the 
analgesic and anaesthetic effects of 40ml Bupivacaine 0.25% alone 
and 40ml of 0.25% Bupivacaine + 2.5 mg/ml of fenlantyl (BF) and 
40ml of 0.125% Bupivacaine plus 2.5mcg/ml of fentanyl. The 
onset time, duration of sensory and motor blocks, duration of 
analgesia were noted. They found out that mean duration of 
sensory block and analgesia were longer in group BF. 
Hemodyanamic parameters similar in all groups. They concluded 
that addition of 100mcg/ml fentanyl to 0.25% Bupivacaine almost 
doubles the duration of analgesia following axillary brachial plexus 
block when compared with 0.25% Bupivacaine alone. 
3. J.E.Bazin, C. Massoni, P. Bruelle, V. Fenis, et al.,34 Department of 
Anesthesia France have compared the duration of analgesia 
produced by a mixture of lignocaine and bupivacaine either alone 
or combined with morphine (75mcg/kg), buprenorphine ( 3mcg/kg) 
or sufentanil (0.2 mcg/kg) in 80 patients after brachial plexus block 
for orthopedic surgery of the upper limb. They concluded that the 
addition of opoids to a local anaesthetic mixture lengthens the 
duration  of analgesia. 
4. Kardash K, Schools A, Concepcion M. et al35 Department of 
Anaesthesia,  Canada have examined the effects of adding fentanyl 
to mepivacaine supraclavicular blocks. They concluded that 
addition of 75mcg of fentanyl to mepivacaine has no significant 
effect on block characteristics. It may enhance postoperative 
analgesia, but the duration of this effect is too brief to be clinically 
useful.  
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5. Mostafa Abdel Hamid Abo Eltnin, Ismail Ewio et al. 37, have 
evaluated the effects of fentanyl to local anesthetic in Peribulbar 
block in patients undergoing vitrectomy due to vitreous 
haemorrhage. Fentanyl group receive 20mcg added to local 
anasthetic. The onset, duration of lid and globe akinesia were 
assessed. Fentanyl group had prolonged duration of analgesia 3.25 
± 0.67 hrs as compared to 1.85 ± 0.67 in control group. They 
concluded that addition of fentanyl to local anaesthetic mixtures 
fastens the onset and prolong the duration of akinesia and improve 
quality of postoperative pain in peribulbar block. 
6. Power, I.B.Sc. Hons, F.C. Anaes, et.al.38, have studied the effects 
of fentanyl, meperidine and diamorphine on A and C fiber 
conduction in an invitro rabbit nerve preparation was examined. 
The effect of fentanyl, meperidine and diamorphine were observed. 
Both fentanyl and meperidine potentiated the block produced by a 
low concentration of bupivacaine. 
MIDAZOLAM IN BRACHIAL PLEXUS BLOCK 
Peripheral GABA receptors 
 Brown et al 44,45 observed that extrasynaptic GABA receptors occur 
on both neuron somatic and unmyelinated axons in the mammalian 
peripheral nervous system Activation of these receptors leads to 
depolarisation, reduced spike amplitude, and slowed conduction probably 
mediated by increased chloride conductance. 
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Midazolam in Brachial Plexus 
 Koj Jarbo et al61 observed that midazolam in combination with 
bupivacaine hastened onset of sensory and motor block and improved 
postoperative analgesia when used in brachial plexus block, without 
producing adverse effects. 
Intrathecal midazolam 
 Batra et al 55 observed that addition of midazolam to bupivacaine 
intrathecally provided better postoperative analgesia without any adverse 
effects. 
 Kim et al54 observed that intrathecal midazolam increases the 
analgesia effects of spinal blockade with bupivacaine in patients 
undergoing hemorroidectomy. 
Epidural Midazolam 
 Nishiyama et al 51,53 observed that adding midazolam to continuous 
epidural infusion of bupivacaine for postoperative pain can provide a 
better analgesia, amnesia and sedation than bupivacaine alone. 
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MATERIALS AND METHODOLOGY 
 60 adult patients of both sexes in the age group of 20-60 years 
belonging to ASA  I / II category and their weight ranging between 40-70 
kgs posted for various types of upper limb surgeries at the Department of 
Orthopedics and Department of Plastic surgery Govt. KMCH formed the 
study group. 
 This study was designed as a prospective randamized comparitive 
study. After receiving the institutional ethical committee approval and 
informed consent, the patients were randomly allocated into 4 groups 
brachial plexus block with Nerve Stimulator was performed with 
supraclavicular block technique. 
GROUPS: 
1. BC – 15 patients received 30ml of 0.25% Bupivacaine with 
1mcg/kg  of preservative free clonidine to the maximum of 75 
mcg. 
2. BF – 15 patients received 30ml of 0.25% Bupivacaine with 
preservative free fentanyl 1 mcg /kg to the maximum of  
50 mcg. 
3. BM – 15 patients received 30ml of 0.25% Bupivacaine with  
preservative free midazolam 50 mcg/kg. 
4. B – 15 patients received 30ml of 0.25% bupivacaine. 
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Inclusion Criteria 
• ASA I & II. 
• Age Group 20-60 years 
• Weight 40 – 70 kgs 
• Surgeries of the upper limb. 
Exclusion Criteria 
• Patients refusal 
• Coagulopathy 
• Infection at Injection site 
Patients were all pre-operatively evaluated, clinically examined and 
investigations done prior to assessment Procedures were explained in 
detail and written consent obtained. 
The procedure was carried out in the theatre where facilities for 
resuscitation were available. 
Equipment 
• Sterile tray 
• Sterile towel with gauze packs. 
• 10ml syringes with local anaesthetic. 
• Sterile gloves with marking pen and surface electrode. 
• 1.5 inch 25 G needle with syringe for skin infiltration. 
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• 3-5 cm long, short, bevel insulated stimulating needle. 
• Peripheral nerve locator. 
Drugs 
- 0.25% Bupivacaine vial 
- Preservative free midazolam 50mcg / ml 
- Preservative free fentanyl ampoule 50mcg / ml 
- Preservative free  Clonidine 150mcg / ml 
Intraoperative and Postoperative Monitor 
• Pulseoximeter 
• NIBP 
• ECG 
Initially the pre procedure parameters were recorded ie. PR, BP, 
SPO2, ECG. Then block was administered. All through the study, these 
parameters were monitered continuously except the NIBP which was 
recorded intermittently. Postoperatively they were monitered for 24 
hours. 
Patients were observed vigilantly for development of various 
complications. 
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SUPRACLAVICULAR BRACHIAL PLEXUS APPROACH 
Indications 
 Surgical – Surgical procedure on the proximal humerus, elbow, 
forearm and hand. 
 Therapeutic – Chronic regional pain syndromes, post amputation 
pain, post herpetic neuralgias. 
Surface Anatomy 
 Important landmarks for supraclavicular block include the 
interscalene groove behind the posterior border of the 
sternocleidomastoid muscle, the clavicle, subclavian pulse. The 
interscalene groove can be identified by placing a finger behind the 
sternocleidomastoid muscle and then rolling laterally. Maneuvers to help 
identify landmarks include asking the patients to lift their head against 
resistance to identify sternocleidomastoid muscle. Sniffing accentuates 
the scalene muscles. The groove can be followed towards the clavicle. 
The external jugular vein crosses the interscalene groove and posterior 
border of sternocleidomastoid muscle at the level of the cricoid cartilage. 
The needle insertion is immediately posterior to the subclavian pulse. 
 Patient is placed in the supine position with the head turned away 
from the side to be blocked. The arm and shoulder is depressed on that 
side. 
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 The skin and subcuteneous tissue is infiltrated with local 
anaesthetic solution. The subclavian artery is palpated above the medial 
third of the clavicle. A 35mm 21G insulated needle is attached to the 
nerve locator set at 1-5mA and inserted through the weal created in 
downward, inward and backward direction, so that it is pointing to the 
spine of second to fourth thoracic vertebra. The superior trunk of the 
brachial plexus is usually located first. The needle position is adjusted 
while decreasing the current to 0.9mA with maintenance of the muscle 
response. 
 The response that results in the greatest block success is muscle 
contraction below the shoulder. A cough from the patient is a warning 
sign that the pleura is being contacted by the needle. Incremental 
injection of local anaesthetic is made with repeated aspiration. 
 After injecting the local anaesthetic the block is tested for both 
sensory (using Pin prick) and motor (using muscle power) and is 
compared with same stimulation or power in the contralateral arm. Motor 
block was evaluated by thumb abduction (Radial Nerve), thumb 
adduction (ulnar nerve), thumb opposition (Median Nerve) and flexion of 
the elbow in supination and pronation of the forearm (musculocuteneous). 
 The Hollmens  scale is used in the study for assessing both sensory 
and motor blockade. 
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Hollmen's Scale 
Sensory blockade (Grade) 
1. 0  - Normal sensation of pin prick  
2. + - Pin prick felt as sharp pointed but weaker compared 
  with the same area in other extremity 
3. ++ - Pin prick felt as touch with blunt object 
4. +++ - No perception of pin prick. 
 Onset of blockade means minimum grade 2 and complete blockade 
means minimum grade 3  
Motor Blockade (Grade) 
1. 0 - Normal muscle function 
2. + - slight depression in muscle function as compared with 
   pre-anaesthetic power 
3. ++ - Very weak muscle action persisting in muscle  
4. +++ - Complete block with absent muscular function. 
 Onset of blockade means minimum grade 2 and complete  
blockade means minimum grade 3. 
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Nerves studied in the block 
Sensory 
Lateral Cuteneous Nerve of arm  
Medial Cuteneous  Nerve of arm  
Medial Cuteneous  Nerve of forearm  
Posterior Cuteneous  Nerve of forearm  
Lateral Cuteneous  Nerve of forearm  
Median Nerve 
Ulnar  Nerve 
Radial Nerve 
Motor 
 Median Nerve 
 Radial Nerve 
 Ulnar Nerve 
 Musculocutenous Nerve 
 Evaluation was carried out for every minute after completion of 
injection and the time of onset was noted both for sensory and motor 
blockade. 
 Onset of blockade both sensory & motor is defined as a minimum 
of grade 2 in Hollmens scale. Block was considered complete when 
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sensory and motor scores were atleast grade 3 in Hollmens scale. Only 
patients with complete block are included in the study. 
 Duration of sensory blockade was considered as the time interval 
between local anaesthetic administration and the onset of paresthesia, 
while the duration of motor block was defined as the time interval 
between local anaesthetic administration and recovery of the block. 
 Sedation was assessed using Sedation scores by Culebras et al 
where sedation was graded on a scale of 1-5 as follows. 
 1. Awake & alert 
 2. Sedated, responding to verbal stimulus 
 3. Sedated, responding to mild physical stimulus 
 4. Sedated, responding to moderate or severe stimulus 
 5. Not arousable 
MONITERING 
 Baseline vital signs PR/ RR/BP/ SPO2 were recorded and 
monitered every 5 mins till the procedures was over and thereafter every 
hour for 24 hours. 
 Onset, completion of blockade, duration of blockade was assessed. 
Pain was assessed using visual analog scale.
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OBSERVATION 
ANALYSIS OF AGE AMONG THE GROUPS 
S.No. Age Group in 
years 
Group 1 
(BC) 
Group 2 
(BF) 
Group 3 
(BM) 
Group 4 
(B) 
1. 20-25 4 6 2 1 
2. 26-35 4 2 6 4 
3. 36-45 1 2 2 5 
4. 46-55 3 5 3 3 
5. 56-65 3 0 2 2 
 
Using Chi Square Test 
  P value = 0.31967  :  Not significant 
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ANALYSIS OF SEX DISTRIBUTION BETWEEN THE GROUPS 
S.No. Sex  Group 1 
(BC) 
Group 2 
(BF) 
Group 3 
(BM) 
Group 4 
(B) 
1. Male 10 12 10 10 
2. Female 5 3 5 5 
 
Using Chi Square Test 
  P value = 0.812772  :  Not significant  
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ONSET  OF SENSORY BLOCK 
 
Group Count Mean Standard Error
1 (BC) 15 4.733333 0.1972027 
2 (BF) 15 6.466667 0.1972027 
3 (BM) 15 5.8 0.1972027 
4 (B) 15 7.6 0.1972027 
 P = 0.0000   < 0.005 Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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ONSET OF MOTOR BLOCK 
 
Group Count Mean Standard Error
1 (BC) 15 6.266667 0.2510296 
2 (BF) 15 7.733333 0.2510296 
3 (BM) 15 7.33333 0.2510296 
4 (B) 15 10.13333 0.2510296 
 P = 0.0000   < 0.005 Significant 
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 Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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COMPLETION OF SENSORY BLOCK 
 
Group Count Mean Standard Error
1 (BC) 15 6.466667 0.2323107 
2 (BF) 15 8.333333 0.23237107 
3 (BM) 15 7.666667 0.2323107 
4 (B) 15 10.73333 0.2323107 
 
 P = 0.0000   < 0.005, Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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COMPLETION OF MOTOR BLOCK 
 
Group Count Mean Standard Error
1 (BC) 15 8.333333 0.2468854 
2 (BF) 15 9.466666 0.2468854 
3 (BM) 15 9.2 0.2468854 
4 (B) 15 13.53333 0.2468854 
 
 P = 0.0000   < 0.005, Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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DURATION  OF SENSORY BLOCK 
 
Group Count Mean Standard Error
1 (BC) 15 602 6.549264 
2 (BF) 15 452 6.549264 
3 (BM) 15 421 6.549264 
4 (B) 15 332 6.549264 
 
 P = 0.0000   < 0.005 Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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DURATION  OF MOTOR BLOCK 
 
Group Count Mean Standard Error
1 (BC) 15 557.3333 7.245962 
2 (BF) 15 414 7.245962 
3 (BM) 15 389 7.245962 
4 (B) 15 292 7.245962 
 
 P = 0.0000   < 0.005 Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
 
 59
VISUAL ANALOG SCALE  - 6 HOURS 
 
Group Count Mean Standard Error
1 (BC) 15 0 0.2606463 
2 (BF) 15 0.9333333 0.2606463 
3 (BM) 15 3.2 0.2606463 
4 (B) 15 5.466667 0.2606463 
 
 P = 0.0000   < 0.005 Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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VISUAL ANALOG SCALE  - 12 HOURS 
 
Group Count Mean Standard Error
1 (BC) 15 4 0.1690308 
2 (BF) 15 5.333333 0.1690308 
3 (BM) 15 6.266667 0.1690308 
4 (B) 15 7.866667 0.1690308 
 
 P = 0.0000   < 0.005 Significant 
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Using multiple comparison test group I (BC) was found to be very 
significant than the other three groups. 
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SEDATION SCORES 
 
Sedation Scores Group I (BC) Group II (BF) Group III (BM)
1 1 (67%) 13 (86%) 0 (0%) 
2 8 (53.3%) 2 (13.3%) 6 (40%) 
3 6 (40%) 0 (0%) 9 (60%) 
 
60% of the patients in Group III (BM) were in sedation scores of 3 
  P = 0.000001,  Significant 
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OBSERVATIONS OF HEMODYANAMIC VARIABLES 
Variables Group I (BC) 
Group II 
(BF) 
Group III 
(BM) 
Group IV 
(B) 
Pulse rate 
15mins 
Mean 78.06667 86.0667 83.93333 82.53333 
Standard 
Error 1.94463 1.94463 1.94463 1.94463 
Probability 
Level 0.036908 Significant 
Pulse rate 
30mins 
Mean 77.06667 85.4 83.4 81.6 
Standard 
Error 1.83541 1.83541 1.83541 1.83541 
Probability 
Level 0.015791 Significant 
Systolic 
BP 15mins 
Mean 122.0667 128.2 132 128.6667 
Standard 
Error 2.790858 2.790858 2.790858 2.790858 
Probability 
Level 0.098164 
Systolic 
BP 30mins 
Mean 118.3333 128.3333 130.7333 126.9333 
Standard 
Error 2.646321 2.646321 2.646321 2.646321 
Probability 
Level 0.009869 Significant 
Diastolic 
BP 15mins 
Mean 77.93333 82.6 82.4 81.33334 
Standard 
Error 1.666 1.666 1.666 1.666 
Probability 
Level 0.180946 Significant 
Diastolic 
BP 30mins 
Mean 76.46667 82.4 81.6 79.53333 
Standard 
Error 1.442 1.442 1.442 1.442 
Probability 
Level 0.024695 Significant 
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DISCUSSION 
 Brachial plexus blockade offers an excellent alternative technique 
to general anaesthesia for upperlimb surgical procedures. Various 
approaches for successful performance of the blocks and for reducing the 
complication have been described. 
 The technique chosen in this study was supraclavicular brachial 
plexus technique. Kulenkampff in Germany in 1911 performed the first 
percuteneous supraclavicular approach. This technique was later 
published in 1928 by Kulenkampff and Persky (Classical) approach). 
 Supraclavicular technique was chosen for this study because it 
provides a rapid onset, dense and predictable anaesthesia with a high 
success rate. 
 Clonidine an α2 – adrenergic agoinst has been extensively used an 
adjunct to general anaesthesia and regional anaesthesia. When added to 
1% mepivacaine6 with 1:2,00,000 epinephrine 150mcg of clonidine 
prolongs the duration of both anaesthesia and analgesia after axillary 
brachial plexus blockade. The minimum dose of clonidine8 required to 
prolong significantly the duration of analgesia and anaesthesia for 
brachial plexus block with 1% mepivacaine is respectively  0.1mcg/kg 
and 0.5mcg/kg. At this dose, clonidine may be used without important 
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reported adverse effects even in outpatients. In this present study 
1mcg/kg to the maximum of 75mcg of clonidine is used.  
It is postulated that clonidine added to local anaesthetics for 
peripheral nerve block prolongs postoperative analgesia and duration of 
block owing to a direct action on the nerve.33,34  
Two mechanisms of action may be proposed. This effect might be 
due to clonidine mediated activation of postsynaptic adrenergic receptors 
leading to vasoconstriction thus prolonging local anaesthesia by 
decreasing the systemic absorption of the local anaesthetic. When applied 
on the rabbit cornea, clonidine is approximately 140 times more potent as 
a surface anaesthetic than procaine. This might indicate that C fibers or 
Aδ fibers, which exclusively innervate the rabbit cornea are especially 
sensitive to clonidine. Butterworth and Strichartz hypothesized that 
analgesia seen after neuraxial application of clonidine might result from 
direct inhibition of impulse conduction in primary afferent nerve fibres. 
They speculate that part of the efficacy of α2 – adrenergic agonists at 
producing analgesia after their regional injection may result from their 
local anaesthetic actions on A α and especially C fibers. 
Fentanyl a synthetic opioid 35-41 and a μ receptor agonist has been 
extensively studied for its use in brachial plexus block. 
 
 65
Nishikawa et al 38 have concluded in their study that fentanyl 
improves analgesia but prolongs the onset of brachial plexus block by 
peripheral mechanism. 
Mostafa et al 39 have studied the effects of addition of fentanyl to 
local anaesthetic in peribulbar block and concluded that addition of 
fentanyl to local anaesthetic mixtures fastens the onset and prolong the 
duration of akinesia and improve the quality of postoperative pain in 
peribulbar block. 
Karakaya et al 35 have studied the analgesic and anaesthetic effects 
of fentanyl with 0.25% bupivacaine and concluded that addition of 100 
mcg/ml fentantyl to 0.25% bupivacaine almost doubles the duration of 
analgesia following axillary brachial plexus block when compared to 
0.25%  bupivacaine alone. 
 Midazolam as an additive to local anaesthesia has been studied in 
intrathecal, epidural and caudal routes. It has been proved in these studies 
that midazolam is as useful additive by way of improved analgesia and 
with sedation. 50mcg/kg midazolam in central neuraxial blockade did not 
produce any significant adverse effects. Studies in animals have showed 
no neurotoxic effects of intrathecally administered midazolam 58,59,60. 
Potentiation of analgesic effects of intrathecal fentanyl with midazolam in 
labouring patients has been demonstrated 61. Intrathecal midazolam 2mg 
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did not increase the occurence of neurologic or urologic symptoms62. 
Hence 50mcg/kg dose was chosen in this study. 
 In this prospective randamised comparitive study, 60 patients 
satisfying  the selection criteria underwent brachial plexus with or 
without adjuvants. Comparison of the onset, completion and duration of 
the block and sedation scores between the three groups and 
hemodyanamic variables were observed and statistically analysed. 
 The onset and completion of the sensory and motor blockade was 
quicker in group I (Bupivacaine + clonidine) followed by group II 
(Bupivacaine + fentanyl) and group III (Bupivacaine + midazolam). 
 Similarly the duration of sensory block was prolonged to last 
longer than motor block in group I (BC) followed by group II (BF) and 
group (III) (BM). This is in line with the observations made by Dejong  
et al who explained that large fibers require a higher concentration of 
local anaesthetic than small fibres. The minimum effective concentration 
of local anaesthetic for large motor fibres is greater than for small sensory 
fibres. Thus motor function return before pain perception and duration of 
motor block is shorter than the sensory block. 
 In this study, the pain scores as assessed by the visual analog scale 
were significantly lower in group I (BC) when compared to the other 
groups. 
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 Sedation scores was higher in group III (BM) when compared to 
group I (BC) & group II (BF). This is due to partial vascular uptake of the 
drug and its transport to the central nervous system where it acts and 
produces sedation. The limited duration of sedation could be explained by 
the fact that it is highly lipophilic and diffuses faster in to the blood 
vessels, by its rapid clearance and short halflife. Highest sedation score 
was 3 ie patient was asleep and arousable by mild physical stimuli. No 
patient required airway compromise or required airway assistance due to 
sedation. 
 Hemodyanamic variables like pulse rate, blood pressure was found 
to altered much in group I (BC) than group II (BF) and group III (BM), 
during the first 30 mins of the intraoperative period. But no patient 
required vassopressor support. The hypotension was only mild and 
corrected only with intravenous crystalloids. 
 No complications with regard to the techniques or drug was 
observed. 
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SUMMARY 
1. Onset and completion time for both sensory and motor blockade 
was quicker in the group I (Bupivacaine plus clonidine group) 
followed by group II (Bupivacaine plus fentanyl) and group III 
(Bupivacaine plus midazolam). 
2. The mean duration of the sensory and motor blockade was 
significantly prolonged in group I (bupivacaine plus clonidine 
group) 
3. Sedation was statistically significant in group III (Bupivacaine plus 
midazolam) in the intraoperative period. 
4. Hemodynamic parameters was found to be altered much in group I 
(BC) than the other groups. 
5. Patient's compliance and acceptance of the block is more with 
group I (BC) and group III (BM) followed by group II (BF) and  
group IV (B). 
6. There was no complication due to addition of 1mcg/kg of clonidine 
to the maximum of 75 mcg and 1mcg/kg of fentantyl to the 
maximum of 50mcg and 50mcg/kg midazolam to bupivacaine. 
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CONCLUSION 
 
 In conclusion, clonidine 1mcg/kg to a maximum of 75mcg added 
to 0.25% Bupivacaine solution for supraclavicular brachial plexus block, 
quickens the onset of sensory and motor blockade, prolongs the duration 
of sensory blockade, improves the quality of postoperative analgesia 
when compared to fentanyl and midazolam group. 
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PROFORMA – 1 
 
Group IV (Bupivacaine) 
 
S. 
No. Age 
Surgery 
Time in 
Mins 
Sex Wt in Kg 
Onset mins Complete mins Duration in mins Sedation 
Scores 
Visual analog 
scale 
Motor Sensory Motor Sensory Motor Sensory 6 hrs 
12 
hrs 
24 
hrs 
1. 29 180 mins M 52 kg 12 9 15 11 300 330 - 6 8 10 
2. 45 210 mins M 61 kgs 9 7 12 10 270 300 - 6 8 10 
3. 54 90 mins M 65 kgs 10 8 14 12 330 360 - 6 8 10 
4. 60 150 mins M 50 kgs 11 9 15 12 270 330 - 4 6 10 
5. 49 110 mins F 65kgs 9 7 12 10 300 330 - 4 8 10 
6. 37 130 mins M 57 kgs 8 6 11 9 270 300 - 4 8 10 
7. 26 170 mins F 50 kgs 8 6 12 9 330 360 - 6 8 10 
8. 57 210 mins M 45 kgs 12 8 15 12 270 300 - 6 8 10 
9. 38 155 mins M 52 kgs 11 7 15 10 300 390 - 6 8 10 
10. 27 130 mins M 59 kgs 10 8 14 12 360 330 - 6 6 10 
11. 23 160 mins F 55 kgs 9 7 13 10 240 300 - 6 8 10 
12. 41 120 mins M 57 kgs 11 9 14 12 330 360 - 6 8 10 
13. 55 150 mins M 68 kgs 12 8 15 11 300 360 - 6 8 10 
14. 39 180 mins F 65 kgs 9 7 12 9 270 330 - 4 8 10 
15. 35 130 mins F 62 kgs 11 8 14 12 240 300 - 6 8 10 
 
PROFORMA – 1 
 
Group I (Bupivacaine + Clonidine) 
 
S.No. 
0 MINS 15 MINS 30 MINS 
RR PR BP SPO2 RR PR BP SPO2 RR PR BP SPO2 
1) 15 88 140/94 99% 15 85 136/90 99% 15 86 135/88 99% 
2) 14 88 124/79 99% 14 78 113/81 99% 15 79 98/75 99% 
3 15 100 130/96 99% 15 96 121/82 99% 15 89 132/84 99% 
4 15 102 110/72 99% 15 98 108/68 99% 15 95 106/72 99% 
5 15 82 136/84 99% 15 74 135/82 99% 15 75 130/74 99% 
6 14 84 130/90 99% 15 78 120/82 99% 15 80 118/72 99% 
7 15 78 156/90 99% 15 75 140/80 99% 15 70 130/80 99% 
8 16 74 110/80 99% 15 68 100/70 99% 15 70 104/72 99% 
9 15 82 140/90 99% 15 79 135/84 99% 15 79 130/80 99% 
10 16 72 118/72 99% 15 71 112/66 99% 15 69 110/72 99% 
11 15 84 130/90 99% 15 80 114/82 99% 15 78 110/82 99% 
12 15 88 146/90 99% 15 78 136/80 99% 15 76 126/78 99% 
13 15 72 110/70 99% 15 65 96/62 99% 15 67 96/64 99% 
14 15 74 150/90 99% 15 68 135/78 99% 15 67 120/74 99% 
15 15 81 138/92 99% 15 78 130/82 99% 15 76 130/80 99% 
 
PROFORMA – 1 
 
Group – II (Bupivacaine + Fentanyl ) 
 
S. 
No. Age 
Surgery 
Time in 
Mins 
Sex Wt in Kg 
Onset mins Complete mins Duration in mins Sedation 
Scores 
Visual analog 
scale 
Motor Sensory Motor Sensory Motor Sensory 6 hrs 
12 
hrs 
24 
hrs 
1. 45 90 mins M 60 7 6 9 8 420 450 1 0 4 10 
2. 21 80 mins M 55 8 7 9 8 420 480 1 0 4 10 
3. 50 150 mins M 65 8 7 10 9 420 450 1 0 4 10 
4. 20 90 mins M 50 8 7 10 9 420 450 2 2 4 8 
5. 24 170 mins F 50 8 7 10 9 420 450 1 2 4 10 
6. 25 110 mins M 55 7 5 9 8 450 480 1 0 4 8 
7. 21 140 mins M 45 9 7 10 9 390 480 1 0 6 8 
8. 49 180 mins M 60 8 7 10 9 420 450 1 2 6 8 
9. 52 150 mins M 65 8 7 9 8 420 450 2 0 6 10 
10 10 210 mins M 50 7 6 9 8 390 450 1 0 6 10 
11. 20 130 mins M 45 9 7 10 9 390 420 1 2 6 10 
12. 48 190 mins F 50 7 6 9 7 450 480 1 2 6 10 
13. 45 70 mins M 60 8 6 10 8 390 450 1 0 6 10 
14. 35 150 mins M 50 7 6 9 8 420 450 1 0 4 10 
15. 35 180 mins F 50 7 6 9 8 390 420 1 0 6 10 
 
PROFORMA – 1 
 
Group II (Bupivacaine + Fentanyl)  
 
S.No. 
0 MINS 15 MINS 30 MINS 
RR PR BP SPO2 RR PR BP SPO2 RR PR BP SPO2 
1) 15 88 140/94 99% 15 87 136/92 99% 15 88 135/88 99% 
2) 16 74 118/72 99% 15 72 115/72 99% 15 71 115/72 99% 
3 15 85 140/92 99% 15 87 136/90 99% 15 88 140/92 99% 
4 15 100 110/74 99% 15 100 114/72 99% 15 99 116/72 99% 
5 15 90 130/80 99% 15 87 130/78 99% 15 85 126/74 99% 
6 15 85 118/72 99% 15 88 120/76 99% 15 84 118/78 99% 
7 17 88 124/82 99% 16 86 124/88 99% 16 85 126/84 99% 
8 16 88 150/90 99% 16 88 147/45 99% 16 87 145/83 99% 
9 16 90 140/84 99% 15 88 135/85 99% 16 89 137/84 99% 
10 15 91 140/90 99% 15 90 141/88 99% 16 87 140/94 99% 
11 16 74 115/74 99% 15 73 118/70 99% 16 71 118/78 99% 
12 16 89 134/90 99% 16 87 127/88 99% 16 88 130/84 99% 
13 16 89 130/90 99% 16 87 127/85 99% 16 88 127/88 99% 
14 15 84 130/90 99% 15 83 125/85 99% 15 83 127/82 99% 
15 16 90 128/90 99% 15 88 127/85 99% 15 88 125/83 99% 
PROFORMA – 1 
 
Group I (Clonidine  + Bupivacaine) 
 
S. 
No. Age 
Surgery 
Time in 
Mins 
Sex Wt in Kg 
Onset mins Complete mins Duration in mins Sedation 
Scores 
Visual analog 
scale 
Motor Sensory Motor Sensory Motor Sensory 6 hrs 
12 
hrs 
24 
hrs 
1. 29 110 mins F 60kg 6 4 8 6 570 630 2 0 4 8 
2. 35 170 mins F 64 6 5 8 7 570 600 2 0 4 10 
3. 48 130 mins F 65 6 5 9 7 530 570 2 0 4 10 
4. 23 70 mins M 50 5 4 7 5 540 600 1 1 3 8 
5. 20 130 mins M 50 6 5 7 6 530 570 2 0 4 8 
6. 29 190 mins M 75 5 4 7 5 600 630 3 0 4 8 
7. 60 170 mins F 50 6 4 8 6 570 630 3 0 4 8 
8. 65 160 mins M 45 6 5 9 7 480 540 3 1 4 10 
9. 55 90 mins M 59 6 4 8 6 570 630 3 0 3 8 
10 20 170 mins M 50  6 4 8 6 570 630 2 0 4 10 
11. 30 130 mins M 60 7 5 9 7 600 630 2 0 4 10 
12. 43 180 mins M 55 7 5 9 7 530 570 2 1 4 8 
13. 23 155 mins F 50 7 6 9 8 530 570 2 0 4 8 
14. 60 210 mins M 75 7 5 9 6 600 630 3 0 4 10 
15. 50 170 mins M 60 8 6 10 8 570 600 3 0 4 8 
 
PROFORMA – 1 
 
Group III (Bupivacaine + Midazolam)   
 
S. 
No. Age 
Surgery 
Time in 
Mins 
Sex Wt in Kg 
Onset mins Complete mins Duration in mins Sedation 
Scores 
Visual analog 
scale 
Motor Sensory Motor Sensory Motor Sensory 6 hrs 
12 
hrs 
24 
hrs 
1. 30 130 mins M 55Kgs 7 6 9 8 390 420 3 6 8 10 
2. 45 180 mins M 70 kgs 9 7 10 8 360 390 2 6 8 10 
3. 60 210 mins F 50 kgs 9 7 11 9 390 420 2 6 8 10 
4. 21 150 mins M 60 kgs 7 6 9 8 390 420 3 4 8 10 
5. 35 180 mins M 55 kgs 7 5 9 7 420 450 3 6 8 10 
6. 52 210 mins M 60kgs 6 5 8 7 390 420 2 6 8 10 
7. 48 160 mins F 60 kgs 7 5 8 6 390 450 3 4 8 10 
8. 45 130 mins M 55 kgs 7 6 9 8 360 390 3 6 10 8 
9. 48 110 mins F 65 kgs 8 6 10 8 390 420 2 6 8 10 
10 35 150 mins F 60 kgs 7 5 9 7 420 450 3 4 8 10 
11. 35 170 mins M 59 kgs 7 6 9 8 360 390 2 4 8 8 
12. 20 155 mins M 50 kgs 8 6 10 8 390 420 2 4 10 8 
13. 29 90 mins F 55 kgs 7 6 9 8 375 405 3 6 10 10 
14. 34 130 mins M 61 kgs 7 6 9 7 420 450 3 6 8 10 
15. 59 150 mins M 53 kgs 7 5 9 7 390 420 3 6 10 10 
 
PROFORMA – 1 
Group III (Bupivacaine + Midazolam) 
 
 
S.No. 
0 MINS 15 MINS 30 MINS 
RR PR BP SPO2 RR PR BP SPO2 RR PR BP SPO2 
1) 15 90 134/82 99% 15 88 132/82 99% 15 88 130/82 99% 
2) 15 84 128/92 99% 15 85 130/90 99% 15 86 128/84 99% 
3 15 74 150/90 99% 15 72 146/88 99% 15 73 144/86 99% 
4 15 88 140/84 99% 15 86 138/86 99% 15 85 137/85 99% 
5 15 91 130/90 99% 15 89 134/88 99% 15 88 134/87 99% 
6 15 87 140/92 99% 14 88 138/90 99% 14 85 130/84 99% 
7 15 85 134/92 99% 15 87 130/90 99% 15 85 128/88 99% 
8 15 74 128/84 100% 15 76 127/80 99% 15 75 125/78 99% 
9 16 78 115/72 99% 15 80 117/74 99% 15 79 118/70 99% 
10 15 83 126/88 100% 15 82 128/86 99% 15 84 126/90 99% 
11 14 92 133/71 99% 14 89 129/76 99% 14 90 130/78 99% 
12 15 100 127/85 100% 15 97 130/82 99% 15 96 132/81 100% 
13 15 79 131/82 99% 15 81 130/78 99% 15 79 131/79 99% 
14 16 85 127/74 100% 16 87 130/76 99% 16 86 128/78 99% 
15 15 69 148/74 100% 15 72 141/70 100% 15 72 140/74 100% 
PROFORMA – 1 
Group IV ( Bupivacaine) 
 
S.No. 
0 MINS 15 MINS 30 MINS 
RR PR BP SPO2 RR PR BP SPO2 RR PR BP SPO2 
1) 15 87 110/72 100% 15 89 112/78 100% 15 87 114/80 100% 
2) 15 82 126/84 100% 15 85 124/80 100% 15 83 118/80 100% 
3 16 79 130/90 100% 16 78 126/84 99% 15 81 127/83 100% 
4 16 71 146/88 99% 16 70 140/80 99% 16 74 138/76 99% 
5 15 88 136/82 100% 15 85 137/83 100% 15 83 130/81 100% 
6 16 72 110/70 99% 16 74 112/72 99% 16 75 110/74 99% 
7 15 74 138/84 100% 15 75 130/80 100% 15 77 132/81 100% 
8 14 82 150/90 99% 14 83 146/84 99% 14 81 145/83 99% 
9 15 75 110/82 99% 15 77 112/84 99% 15 79 110/80 99% 
10 14 87 132/84 99% 14 89 136/82 99% 14 87 133/81 99% 
11 15 91 140/85 100% 15 89 139/83 100% 15 85 137/80 100% 
12 15 85 124/84 100% 15 84 120/85 100% 15 81 118/87 99% 
13 15 96 128/82 99% 15 97 126/78 99% 15 100 128/74 99% 
14 14 78 130/84 99% 14 80 130/87 99% 14 82 128/79 99% 
15 15 81 142/84 100% 15 83 140/80 100% 15 79 136/74 99% 
 
Name  : 
Age  : 
Sex  : 
Surgery : 
Group  : 
Wt  :       PROFORMA – II 
 
Vital 0 5min 10 min 15 20 
30 
mins 1 hr 2 3 4 5 6 12 24 hrs 
 PR               
 BP               
 SPO2               
 RR               
SENSORY AND MOTOR SCORE               
RADIAL NERVE 
SENSORY               
MOTOR               
MEDIAN NERVE 
SENSORY               
MOTOR               
ULNAR NERVE 
SENSORY               
MOTOR               
MUSCULOCUTENEOUS NERVE 
SENSORY               
MOTOR               
SENSORY SCORE               
Lateral Cuteneous Nr. of the arm               
Medial Cuteneous Nr. of the arm               
Lateral Cuteneous Nr. of the fore arm               
Medial Cuteneous Nr. of the fore arm               
 
